LOS ANGELES--Pearl, the global leader in dental AI solutions, announced today that it has been included on the 2022 list of "Hot Vendors" in Computer Visioni by Aragon Research, Inc. The firm’s report identifies vendors whose technology provides transformative capabilities that revolutionize the way businesses interact with customers.
This recognition from Aragon Research further validates our efforts to fundamentally change dental diagnosis, treatment, clinical performance, and practice management.
Pearl is leading the worldwide dental artificial intelligence (AI) revolution with a suite of computer vision solutions, including Second Opinion® and Practice Intelligence®, that aim to enhance the standard of patient care in dentistry. Second Opinion® is the first and only FDA-cleared chairside AI software to help dentists detect numerous pathologies in x-rays of dental patients 12 and older. It identifies and highlights key pathologic and non-pathological findings, supporting dental professionals in their review of radiographs. Practice Intelligence® applies those same AI dental disease detection capabilities in conjunction with patient treatment data to uncover actionable insights and help streamline dental practices’ clinical and operational performance. These solutions improve precision and diagnostic consistency across the dental field, significantly enhancing the patient care experience.
“This recognition from Aragon Research further validates our efforts to fundamentally change dental diagnosis, treatment, clinical performance, and practice management,” said Ophir Tanz, founder and CEO of Pearl. “Our advanced clinical AI solutions are helping dental practices around the world consistently deliver a higher standard of care, facilitating clearer communication with patients and promoting greater trust in providers.”
In December, the Aragon Research Hot Vendors will be formally recognized at an award ceremony at Aragon Transform. To learn more about the other vendors included, read the full Aragon Research report here.